- This initiative aims to raise awareness of the role of virtual twins in accelerating medical research and delivering personalized care
- On social media, Emma Twin will document how she, as a virtual twin, helps doctors and researchers better understand diseases and the effects of treatments, without risk to real patients
- For 40 years, Dassault Systèmes’ virtual twins have been improving quality of life for patients, citizens and consumers
VELIZY-VILLACOUBLAY, France–(BUSINESS WIRE)–#3DEXPERIENCE—Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today introduced “Emma Twin,” an avatar designed to raise awareness of the key role that virtual twins have in advancing healthcare and the innovations that are shaping the future of medicine.
Through a rich social media program, Emma Twin will share stories explaining how the virtual twin of her body was created from anonymous health data to be used for an infinite number of tests that give doctors and researchers a profound understanding of diseases and the effects of new and improved treatments.
Her social media posts will document her participation in ongoing research and medical innovations including: clinical trials using Medidata solutions; the reaction of her heart to different procedures in the Living Heart project; testing CorNeat Vision’s corneal transplants; epilepsy and Alzheimer’s disease studies in the Living Brain project; wearing the IASO drug administration and monitoring device; and optimizing the home for older adults. They will also highlight: DAMAE Medical’s portable microscope for detecting skin cancer; Dynocardia’s blood pressure monitoring solution; FEops’ cardiac monitoring; LUCID Implants’ customized facial implants; and the VORTHEx radiotherapy simulation experience.